Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Cognitive Dysfunction × 90 days × Clear all
NCT05637801 2026-05-05

HOPE

Cognito Therapeutics, Inc.

Phase NA Active not recruiting
670 enrolled
Lymphoid

Alzheimer disease type 1, Alzheimer disease type 2, Alzheimer disease type 4, Alzheimer disease, familial, type 3, Alzheimer Disease 9, Alzheimer Disease 8, Alzheimer Disease 11, Alzheimer Disease 7, Alzheimer Disease 6, Alzheimer Disease 10, Alzheimer Disease 5, Alzheimer Disease 15, Alzheimer Disease 14, Alzheimer Disease 13, Alzheimer Disease 12, Alzheimer Disease 16, Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction